Ovid Therapeutics (OVID)

• Market cap: $470M
• 1 day: -3.08%
• 5 days: -9.03%
• 1 month: 10.53%
• 3 months: -8.36%
• 6 months: 56.52%
• Year to date: 43.18%
• 1 year: 501.43%
• 5 years: -35.55%
• 10 years: -79.43%
• Sector: Healthcare
• Industry: Biotechnology

About: Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Employees: 23